Gold nanoparticles can spot biomarker for blood clots

04/12/2010 | MIT Technology Review

Scottish scientists have developed gold nanoparticles that enable them to measure concentrations of thrombin, a protein linked to blood clots, in blood specimens using laser light. They hope the technology leads to tests in which patients are implanted with nanosensors to help detect blood clots and other diseases.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX